2024-03-21T12:33:08-05:00 2023-06-30 521853933 JM&M 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2022-07-01 453568770 AMERICAN COCHLEAR IMPLANT ALLIANCE FOUNDATION AMER 7035346146 PO BOX 103 MCLEAN VA 221010103 DONNA SORKIN EXECUTIVE DIRECTOR 7035346146 2024-03-21 1 DONNA SORKIN 999009999 1 P01608821 4108840220 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DONNA SORKIN PO BOX 103 MCLEAN VA 221010103 1300553 0 X WWW.ACIALLIANCE.ORG X 2011 DE TO ADVANCE ACCESS TO THE GIFT OF HEARING PROVIDED BY COCHLEAR IMPLANTATION THROUGH RESEARCH, ADVOCACY AND AWARENESS. 16 16 4 17 12000 0 824841 718534 699538 560745 249 16326 0 4948 1524628 1300553 0 1920 0 0 559256 538221 0 0 30001 864430 880095 1423686 1420236 100942 -119683 2807367 2621143 597293 529328 2210074 2091815 TO ADVANCE ACCESS TO THE GIFT OF HEARING PROVIDED BY COCHLEAR IMPLANTATION THROUGH RESEARCH, ADVOCACY AND AWARENESS. 0 0 718968 AWARENESS - THE ACI ALLIANCE CONDUCTS AWARENESS ACTIVITIES ABOUT CANDIDACY AND OUTCOMES ASSOCIATED WITH COCHLEAR IMPLANTATION. THE ACI ALLIANCE PROVIDES EXTENSIVE INFORMATION ABOUT INSURANCE COVERAGE AND OTHER ACCESS ISSUES THROUGH ITS WEBSITE AND ARTICLES, PAPERS AND PRESENTATIONS. ADDITIONALLY, THE ACI ALLIANCE ENCOURAGES COVERAGE OF COCHLEAR IMPLANTS IN PRIVATE AND PUBLIC INSURANCE PLANS. 260000 RESEARCH - THE ACI ALLIANCE STRATEGICALLY SUPPORTS RESEARCH THAT COULD IMPROVE ACCESS TO COCHLEAR IMPLANTATION, WHICH WAS NOT BEING SUFFICIENTLY ADDRESSED ELSEWHERE. PROJECT SUPPORT WAS PROVIDED TO MEDICAL UNIVERSITY OF SOUTH CAROLINA TO EXPLORE THE DEVELOPMENT OF NEW INSTRUMENTS THAT MAY PROVIDE A MORE COMPREHENSIVE AND PATIENT-CENTERED UNDERSTANDING OF CI PATIENT OUTCOMES THAN JUST USING SPEECH RECOGNITION. SUPPORT WAS ALSO PROVIDED TO A PROJECT THAT SEEKS TO EXPAND MEDICARE COVERAGE FOR COCHLEAR IMPLANTS. AN INTERNAL RESEARCH PROJECT EXPLORED MEDICAID LIMITATIONS IN CERTAIN STATES. 180000 1920 548745 ANNUAL CONFERENCE - THE CONFERENCE BRINGS TOGETHER COCHLEAR IMPLANT CLINICIANS, EDUCATORS, AND GOVERNMENT OFFICIALS TO EXPLORE THE LATEST RESEARCH RESULTS, DISCUSS THE CLINICAL POPULATION, AND RAISE QUESTIONS REGARDING CLINICAL IMPLICATIONS. 1158968 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 4 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 16 16 0 0 0 0 1 1 0 1 1 0 0 0 1 1 1 0 0 0 0 0 VA X SMITHBUCKLIN CORPORATION 8005399740 2001 K STREET NW 300 WASHINGTON DC 20006 DONNA SORKIN EXECUTIVE DIRECTOR 40.00 X 191360 0 5741 LAURA ODATO DIRECTOR OF OPERATIONS AND MARKETING 40.00 X 118000 0 3540 NICHOLE J WESTIN DIRECTOR OF GOVERNMENTAL AFFAIRS 40.00 X 104832 0 0 OLIVER F ADUNKA MD CHAIR UNTIL 6/2023, THEN DIRECTOR 5.00 X X 0 0 0 ANDREA WARNER-CZYZ PHD SECRETARY UNTIL 6/2023, THEN CHAIR 3.00 X X 0 0 0 MELISSA JW HALL AUD CCC-ASLP VICE CHAIR UNTIL 6/2023, THEN SEC. 3.00 X X 0 0 0 DAVID KELSALL MD DIR. UNTIL 6/2023, THEN VICE CHAIR 3.00 X X 0 0 0 KEVIN D BROWN MD PHD TREASURER 3.00 X X 0 0 0 AMY BIRATH AUD DIRECTOR 3.00 X 0 0 0 CAMILLE C DUNN PHD CCC-A DIRECTOR 3.00 X 0 0 0 FRED TELISCHI MD DIRECTOR 3.00 X 0 0 0 DAN ZEITLER MD DIRECTOR 3.00 X 0 0 0 BARBARA MELLERT MPH DIRECTOR 3.00 X 0 0 0 JOHN DORNHOFFER MD DIRECTOR 3.00 X 0 0 0 BRITTNEY SPROUSE AUD PASC DIRECTOR 3.00 X 0 0 0 KRISTIN LEWIS DIRECTOR AS OF 6/2023 3.00 X 0 0 0 MAURA COSETTI DIRECTOR AS OF 6/2023 3.00 X 0 0 0 MATT BUSH DIRECTOR AS OF 6/2023 3.00 X 0 0 0 LINDSEY ZOMBEK DIRECTOR AS OF 6/2023 3.00 X 0 0 0 LORI BOBSIN PHD DIRECTOR UNTIL 2/2023 3.00 X 0 0 0 414192 0 9281 3 0 1 0 AMERICAN COLLEGE OF SURGEONS 20 F STREET NW 1000 WASHINGTON DC 20001 MEETING PLANNING SERVICES 145769 1 201584 80000 436950 718534 CONFERENCE REVENUE 900099 548745 548745 ADVERTISING 541800 12000 12000 560745 16326 16326 MISC. REFUNDS 900099 4948 4948 4948 1300553 548745 12000 21274 X 1920 1920 197101 158272 27929 10900 302548 242946 42871 16731 3165 2542 448 175 35407 28432 5017 1958 4462 4462 37950 37950 175 175 364417 362838 1579 200 200 49893 26448 23445 88381 44363 44018 33149 10438 22711 208094 197374 10720 500 402 70 28 6909 6909 ADVISORY 76583 76583 CONTINUING EDUCATION 6210 6210 DUES AND SUBSCRIPTIONS 2318 2109 209 MISCELLANEOUS 854 854 1420236 1158968 231267 30001 1893450 1570255 776357 793928 25000 200000 106628 49589 5349 7288 4225 4142 583 83 2807367 2621143 520759 516328 12000 12000 64534 1000 597293 529328 X 2203012 2084753 7062 7062 2210074 2091815 2807367 2621143 -119683 1424 0 X 0 1 X 0 0 X 674047 806242 1009398 824841 718534 4033062 674047 806242 1009398 824841 718534 4033062 1758600 2274462 4934 13890 6039 249 16326 41438 530 4948 5478 4079978 2490167 0.55750 0.53060 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: REFUNDS - 2019 AMOUNT: $ 530. 2022 AMOUNT: $ 4,948. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 1 0 0 1 45604 0 0 45604 0 PART II-B, LINE 1: ACIA ADVOCATES IN WASHINGTON TO EXPAND KNOWLEDGE ABOUT COCHLEAR IMPLANTS AND ISSUES OF ACCESS, AND STATE CHAMPIONS MONITOR AND INITIATE PROACTIVE MEASURES TO ADDRESS COCHLEAR IMPLANT INSURANCE COVERAGE AT THE STATE AND FEDERAL LEVELS. 4225 4142 83 83 X 1301802 1424 1424 1300378 175 175 1300553 1420061 0 1420061 175 175 1420236 PART X, LINE 2: ACI ALLIANCE BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. X 0 0 0 0 0 0 0 0 0 DONNA SORKIN EXECUTIVE DIRECTOR 191360 0 0 0 0 0 5741 0 0 0 197101 0 0 0 FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE SHALL BE A COMMITTEE OF THE BOARD AND SHALL BE COMPOSED OF THE CHAIR OF THE BOARD, THE VICE CHAIR OF THE BOARD, THE SECRETARY, THE TREASURER, THE CHAIR OF MEMBERSHIP, THE CHAIR OF NOMINATING AND OTHER CHAIRS AS THE BOARD OF DIRECTORS SO DESIGNATES. THE CHAIR SHALL SERVE AS THE CHAIRPERSON AND THE SECRETARY SHALL SERVE AS THE SECRETARY OF THE EXECUTIVE COMMITTEE. THE HONORARY CHAIRMAN OF ACIA MAY ALSO SERVE AS AN EX-OFFICIO, NON-VOTING MEMBER. EXCEPT FOR THE POWER TO AMEND THE ARTICLES OF INCORPORATION AND BYLAWS, THE POWER TO REMOVE OR FILL VACANCIES OF DIRECTORS OR OFFICERS, AND SUCH OTHER POWERS AS MAY BE RESERVED TO THE BOARD BY LAW, THE EXCECUTIVE COMMITTEE SHALL MANAGE THE AFFAIRS OF ACIA REQUIRING ATTENTION BETWEEN THE MEETINGS OF THE BOARD AND SHALL HAVE THE POWER TO CONDUCT THE CURRENT AND ORDINARY BUSINESS OF ACIA WHILE THE BOARD OF DIRECTORS IS NOT IN SESSION. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS 2 CLASSES OF MEMBERS; VOTING AND NON-VOTING. CORPORATE MEMBERS HAVE NO VOTING RIGHTS, NOR ARE THEY ELIGIBLE TO HOLD OFFICE. ALL OTHER MEMBERS HAVE VOTING RIGHTS. FORM 990, PART VI, SECTION A, LINE 7A VOTING MEMBERS OF ORGANIZATION HAVE THE POWER TO ELECT OR APPOINT MEMBERS OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS REVIEWED BY THE EXECUTIVE DIRECTOR AND TREASURER PRIOR TO FILING. THE EXECUTIVE COMMITTEE IS SENT THE FINAL 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION ANNUALLY REVIEWS THEIR CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION C, LINE 19 AMERICAN COCHLEAR IMPLANT ALLIANCE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 142,109. MANAGEMENT AND GENERAL EXPENSES 1,579. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 143,688. CONTRACT LABOR: PROGRAM SERVICE EXPENSES 220,729. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 220,729.